http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1122543-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3615c23ca02b8b36fcd7896f93aec1f |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
filingDate | 2000-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc101d4912a0e7eff34d14aa8962a6c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2223e14322aaabee215670f6bf45712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32fcf082d46fee38379cbf6ad10c85cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c52c808c9bee0e56fe2435eeca6d8487 |
publicationDate | 2001-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1122543-A1 |
titleOfInvention | Immunoassay for human medullasin and multiple sclerosis |
abstract | There is provided an immunoassay by which the amount of human medullasin present inside granulocytes, which are one leukocyte component in blood, can be determined with high accuracy and with good reproducibility. An immunoassay of medullasin, wherein when measuring the medullasin in blood using an anti-human medullasin antibody, the determination of the amount of human medullasin in a blood sample using said anti-human medullasin antibody is carried out after treating the blood sample with an aqueous liquid having a specific osmotic pressure different to the osmotic pressure of blood to completely break up the leukocytes; and a method of diagnosing multiple sclerosis characterized in that the human medullasin content of a blood sample is measured using an immunoassay, and the onset of multiple sclerosis and the extent of the disease is diagnosed according to the size of, or changes in, this measured value. <IMAGE> |
priorityDate | 2000-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 277.